| Metabolism of thalidomide by human liver microsome cytochrome CYP2C19 is required for its antimyeloma and antiangiogenic activities in vitro. | |
| | |
MedLine Citation:
|
PMID: 21638302 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
In this study, we used a system of human liver microsomes to investigate the antimyeloma and antiangiogenic activities of thalidomide. Myeloma cells and human umbilical vein endothelial cells (HUVECs) were treated with thalidomide alone or thalidomide incubated with human liver microsomal protein. We found that thalidomide alone had no direct effect on several multiple myeloma cell lines (U266, NCI-H929, RPMI 8226, LP-1, CZ-1) or on HUVECs in vitro. However, when incubated with human liver microsomal protein, thalidomide (100 µg/ml) caused a decrease of 34.9-46.7% in cell viability in myeloma cells and 12% in HUVECs. Cell cycle analysis and apoptosis detection indicated that the decreases in cell viability were correlated with the induction of apoptosis. Thalidomide incubated with microsomal protein also influenced HUVEC migration and tube formation. These effects were partially reversed by omeprazole (10 µmol/l), a potent inhibitor of CYP2C19, suggesting that CYP2C19 is required for thalidomide to exhibit its antimyeloma and antiangiogenic activities. Copyright © 2011 John Wiley & Sons, Ltd. |
| | |
Authors:
|
Yonghua Li; Zujun Jiang; Yang Xiao; Li Li; Yang Gao |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-6-3 |
Journal Detail:
|
Title: Hematological oncology Volume: - ISSN: 1099-1069 ISO Abbreviation: - Publication Date: 2011 Jun |
Date Detail:
|
Created Date: 2011-6-3 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8307268 Medline TA: Hematol Oncol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 John Wiley & Sons, Ltd. |
Affiliation:
|
Department of Hematology, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Assessment of a disease screener by hierarchical all-subset selection using area under the receiver ...
Next Document: Clinical implications of acute myeloid leukemia presenting as myeloid sarcoma.